Lanirapid and Voltaren drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lanirapid (metildigoxin) and Voltaren (diclofenac sodium). Common drug interactions include depressed level of consciousness among females and cholangitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Lanirapid and Voltaren. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Lanirapid?

Lanirapid has active ingredients of metildigoxin. eHealthMe is studying from 1,259 Lanirapid users. Check the latest studies of Lanirapid.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,345 Voltaren users. Check the latest studies of Voltaren.

On Feb, 08, 2026

11 people who take Lanirapid and Voltaren together, and have interactions are studied.

Lanirapid and Voltaren drug interactions.

What are the common drug interactions of Lanirapid and Voltaren, by gender? *:

female:

Depressed level of consciousness
Hepatic failure (liver failure)
Hyperkalaemia (damage to or disease of the kidney)
Renal failure (kidney dysfunction)
Abdominal distension
Anaemia (lack of blood)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Infection
Renal failure acute (rapid kidney dysfunction)

male:

Cholangitis acute (rapid infection of bile duct)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Dyspnoea (difficult or laboured respiration)
Heart rate decreased
Heart rate irregular
Hypotension (abnormally low blood pressure)
Renal failure acute (rapid kidney dysfunction)
Renal impairment (severely reduced kidney function)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Respiratory distress (difficulty in breathing)

What are the common drug interactions of Lanirapid and Voltaren, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Depressed level of consciousness
Hepatic failure (liver failure)
Hyperkalaemia (damage to or disease of the kidney)
Renal failure (kidney dysfunction)
Abdominal distension
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

60+:

Cholangitis acute (rapid infection of bile duct)
Renal failure acute (rapid kidney dysfunction)
Brain natriuretic peptide increased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Dehydration (dryness resulting from the removal of water)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dyspnoea (difficult or laboured respiration)
Heart rate decreased
Heart rate irregular
Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 36.36%
Pain In Extremity: 2 people, 18.18%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 18.18%
Breast Cancer Recurrent: 2 people, 18.18%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 1 person, 9.09%
Pain: 1 person, 9.09%
Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue): 1 person, 9.09%
Joint Pain: 1 person, 9.09%
Hypopharyngeal Cancer: 1 person, 9.09%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lanirapid and Voltaren?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously